Skip to main content
Frontiers in Bioengineering and Biotechnology logoLink to Frontiers in Bioengineering and Biotechnology
. 2020 Jul 31;8:821. doi: 10.3389/fbioe.2020.00821

Corrigendum: Immobilization of Growth Factors for Cell Therapy Manufacturing

Daniela Enriquez-Ochoa 1, Pedro Robles-Ovalle 1, Karla Mayolo-Deloisa 1,*, Marion E G Brunck 1,*
PMCID: PMC7438897  PMID: 32903834

In the original article, there was a mistake in Figures 1, 2 as published. The order of the figures was reversed while the legends of these figures were correct.

Figure 1.

Figure 1

Overview of methods currently in use to perform physical GF immobilization.

Figure 2.

Figure 2

Overview of current chemical immobilization strategies. In covalent methods, acrylate crosslinking is representative of the conjugation of an acryloyl GF and PEG-diacrylate matrix. While, mussel-based immobilization shows the interaction between the GF and polydopamine coated on the surface.

The corrected Figures 1, 2 appear below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Frontiers in Bioengineering and Biotechnology are provided here courtesy of Frontiers Media SA

RESOURCES